Bacteremia from Alcaligenes xylosoxidans after ERCP in a Pancreas Cancer Patient
Author Information
Author(s): Yilmaz Gurdal, Aydin Kemalettin, Koksal Iftihar, Caylan Rahmet, Akcay Korhan, Arslan Mehmet
Primary Institution: Karadeniz Technical University School of Medicine, Trabzon, Turkey
Conclusion
The case report highlights that Alcaligenes xylosoxidans can cause post-ERCP bacteremia in immunocompromised patients.
Supporting Evidence
- Alcaligenes xylosoxidans is a rare cause of bacteremia, particularly in immunocompromised patients.
- The patient had symptoms of infection one day after ERCP, suggesting a rapid onset of bacteremia.
- The bacterium was identified through blood culture and biochemical tests.
Takeaway
A patient with pancreas cancer got a serious infection after a medical procedure, and doctors found a rare germ in his blood that caused it.
Methodology
The case report describes a 70-year-old man with pancreas cancer who developed bacteremia after ERCP, with microbiological analysis confirming the presence of Alcaligenes xylosoxidans.
Limitations
The report is based on a single case, limiting the generalizability of the findings.
Participant Demographics
A 70-year-old male with a history of pancreas cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website